Literature DB >> 3311358

The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.

V T De Vita1, S M Hubbard, D L Longo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311358

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  20 in total

Review 1.  Pharmacology of anticancer drugs in the elderly population.

Authors:  Hans Wildiers; Martin S Highley; Ernst A de Bruijn; Allan T van Oosterom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG).

Authors:  V Diehl
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

3.  Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.

Authors:  S D Harrison; J Plowman; D J Dykes; W R Waud; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  GM-CSF, carboplatin, doxorubicin: a phase I study.

Authors:  E A Poplin; D S Alberts; J J Rinehart; H O Smith; J A Neidhart; E M Hersh
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.

Authors:  M De Lena; E Maiello; V Lorusso; M Brandi; P Calabrese; S Romito; A Mazzei; F Marzullo
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

6.  Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group.

Authors:  B Hoerni; M B Orgerie; H Eghbali; C M Blanc; B David; J Rojouan; R Zittoun
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

8.  Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events.

Authors:  D R Dowd; R L Miesfeld
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

Review 9.  Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.

Authors:  Julia Bohlius; Christine Herbst; Marcel Reiser; Guido Schwarzer; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

10.  Peritonectomy procedures.

Authors:  P H Sugarbaker
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.